Brief: Index Pharmaceuticals Aims To Carry Out Uplisting To Nasdaq Stockholm
07/06/2024 15:32
June 7 (Reuters) - InDex Pharmaceuticals Holding AB INDEX.ST :
* HAS RECEIVED A CONDITIONAL APPROVAL FOR CONTINUED LISTING ON NASDAQ FIRST NORTH GROWTH
MARKET
AFTER THE REVERSE MERGER OF FLERIE
* AIMS TO CARRY OUT UPLISTING FROM NASDAQ FIRST NORTH GROWTH MARKET TO NASDAQ STOCKHOLM
* FIRST DAY OF TRADING ON NASDAQ STOCKHOLM IS PLANNED TO TAKE PLACE AROUND JUNE 27, 2024
Source text for Eikon: ID:nWkr3P5ply
Further company coverage: INDEX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))